Clinical Trials Directory

Trials / Unknown

UnknownNCT01108614

Injecting Drug Use Community Intervention Trial

A Randomized Community Intervention Trial on Reducing HIV Infection Among Drug Users Attending Methadone Maintenance Treatment(MMT) and Preventing Secondary Transmission From HIV Positive Clients to Their Sexual Partners in China

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
12,000 (estimated)
Sponsor
National Center for AIDS/STD Control and Prevention, China CDC · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to reduce the HIV/HCV incidence among the clients attending community-based methadone maintenance treatment (MMT) , and to prevent the secondary sexual transmission from HIV+ clients to their spouse and sex partners, through intensified comprehensive intervention.

Detailed description

Even though National sentinel surveillance data show that the increase rate of HIV new infections among IDUs in China has become stabilized and slowed down, the new HIV infection is still on the rise, especially in the Yunnan, Guizhou, Guangxi, Xinjiang and Sichuan. This study attempts to further reduce the new infection among MMT clients, and particularly to prevent the transmission from HIV infected clients to their sexual partners with comprehensive intervention. The purposes of this study are: 1. To evaluate the effectiveness of comprehensive interventions to decrease the HIV/STIs incidence among MMT clients. 2. To prevent the sexual transmission between those HIV+ clients and their spouse/partners with intensified intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInterventionIntensive HIV psychological counseling ,Increased methadone dosage under individualized treatment principle, enhance randomized urine test, strengthen family and social support , partner notification and routine HIV testing, condom promotion, STD referral services.

Timeline

Start date
2009-06-01
Primary completion
2010-12-01
Completion
2011-03-01
First posted
2010-04-22
Last updated
2010-05-07

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01108614. Inclusion in this directory is not an endorsement.